You are subscribed to the FormularyWatch.

Formulary

eNewsletter Subscribe

February 13, 2015

Web Version  | Share with a colleague

Facebook Like Twitter Tweet

Today's Headlines

7 FDA-approved smoking cessation medications

Formulary managers have an important role to play in helping smokers quit by ensuring that health plans are covering all 7 FDA-approved quit-smoking medications and all 3 forms of quit-smoking counseling. » Ways to partner with the American Lung Association

E-Rx tool for controlled substances launches, integrates with EHRs

Imprivata has launched a new product to enable a major shift from paper to electronic prescribing of controlled substances. » Tool can reduce of physician DEA number theft and Rx fraud and abuse.

Continuing Education

New and emerging therapies for the treatment of diabetes

This month and next month pharmacists will be able to learn about the latest developments in diabetes treatment and management. Pharmacists can earn up to 4 hours of CPE credit with two monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month's activity is to discuss new and emerging medications for the treatment of diabetes.

Read/print the article: Click here

Take the test: Click here to log in with the Session Code 15DT15-WKX27.


Announcement: Our CE activities have moved to a new learning management system to better serve you. The login to the Online CE Center is https://web2.uconn.edu/pharmacyce/login.php. All current user registration information has been uploaded for your convenience. Current users do not need to register. To review your registration page to ensure the data is up to date or to register, go to https://web2.uconn.edu/pharmacyce/program_register.php. For a full list of courses, go to http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/

EDITOR'S PICK

PCORI to give $138M to disease researchers

The Patient-Centered Outcomes Research Institute (PCORI) has issued 6 new funding announcements offering up to $138 million in support for studies comparing how well different approaches to care work for patients given their particular circumstances and concerns. » Details

 

RELATED ARTICLES

FDA: Keep boxed warning on Chantix

E-prescribing rates soar among physicians

RESOURCES

Latest Clinical News

Powered by Modern Medicine Advanstar Medical Communications Group